SciDev.Net
Science and Development Network
News, views and information about science, technology and the developing world
Search Archive
News archive results 1-20 of 349 in Health and HIV/AIDS
Misfiring immune system blamed for HIV vaccine failure
An HIV vaccine component may have accidentally triggered an immune response that made people more vulnerable to infection, say scientists.
Electricity sparks better HIV vaccine response
Scientists have used a 'gun' that delivers a vaccine and an electrical impulse to improve the effectiveness of a DNA vaccine for HIV.
Thai HIV trial shines light on research mystery
The Thailand HIV vaccine trial reveals the human body's fighting response to the virus, a conference has heard, but many questions remain.
'Low condom use' among young HIV-infected Haitians
Although 87.5 per cent of young HIV-infected Haitians know how to prevent disease spread, their behaviour is frequently risky, says a study.
NEWS | 1 October 2009 | ES
Breakthrough HIV vaccine first to cut infection rates
An experimental HIV vaccine trialled in Thailand has reduced infection rates for the first time, by almost a third.
Scientists and healers team up to test AIDS remedy
South African researchers are probing the AIDS-fighting potential of local plants, signalling a new alliance with healers.
NEWS | 24 September 2009 | EN
Honduras: high prevalence of HIV resistance
Researchers have shown that there is a high prevalence of resistance against antiretrovirals in HIV patients in Honduras.
NEWS | 10 September 2009 | ES
Gel could block HIV like a condom
A gel that turns to a semisolid in the presence of semen shows promise as a barrier against HIV transmission.
Starting HIV therapy early 'improves chances of survival'
Starting antiretroviral therapy when the immune system is not severely compromised reduces mortality, says a Haitian study.
NEWS | 7 August 2009 | ES
Brazil has paved way for tackling HIV/AIDS, says study
Brazil's strategy for tackling HIV/AIDS — including the production of generic drugs — is an example to the developing world, say researchers.
Antiretroviral microbicides enter clinical trials
Testing is under way for microbicidal gels containing antiretroviral drugs that could inhibit HIV infection.
NEWS | 24 July 2009 | EN
Rapid tests monitor HIV patients' health
Tests providing fast, inexpensive ways to assess whether HIV/AIDS patients need treatment made their debut this week.
NEWS | 23 July 2009 | EN
Trial of Africa's first HIV vaccines underway
Africa's first home-grown HIV vaccines have started early-stage clinical trials in South Africa and the United States.
NEWS | 23 July 2009 | EN
Syringe use 'main cause' of HIV in Puerto Rico
Despite national prevention programmes, a study has found that shared syringes are the most common mode of HIV transmission in Puerto Rico.
NEWS | 25 June 2009 | ES
HIV test needs just a spot of blood
A simple HIV test could remove the obstacles to treating HIV-positive babies in their first year, say scientists.
Promising microbicide can be produced by plants
A microbicide has shown promise in the lab and can be produced in plants — a double blow toHIV in the developing world, scientists say.
Rates of HIV-positive newborns reduced in Haiti
A pilot programme aiming to reduce mother-to-child transmission of HIV has reduced infection in babies from 27 to nine per cent.
NEWS | 9 April 2009 | ES
New South African research centre to tackle HIV/TB
South Africa's University of KwaZulu-Natal will be home to a new HIV/TB research hub focused on combatting the dual infection.
NEWS | 2 April 2009 | EN
HIV/AIDS: Genetic variability 'increasing' in Americas
Venezuelan scientists have shown that although HIV/AIDS subtype B is still predominant in the Americas, other variants have been increasing in frequency.
NEWS | 30 March 2009 | ES
HIV/TB alliance deadlier than thought, warns report
A quarter of TB deaths occur in HIV patients, says the WHO — double the previous estimate.
Information Services
Missed the Global Health Forum 2009?
Our blog, by SciDev.Net columnist Priya Shetty, will fill you in, as will our interview with the Global Forum's Gill Samuels
.jpg)
